Deborah A Young

Title: Innovations of Deborah A Young

Introduction

Deborah A Young is a prominent inventor based in Melrose, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of binding proteins related to the interleukin-21 receptor. With a total of 10 patents to her name, her work has the potential to impact various medical treatments and therapies.

Latest Patents

Her latest patents include innovative methods of treatment utilizing binding proteins of the interleukin-21 receptor. The first patent provides binding proteins and antigen-binding fragments that specifically bind to the human interleukin-21 receptor (IL-21R). These binding proteins can act as antagonists of IL-21R activity, modulating immune responses and addressing IL-21R-associated disorders such as inflammatory disorders, autoimmune diseases, allergies, and transplant rejection. The second patent also focuses on interleukin-21 receptor binding proteins, emphasizing their role in diagnosing and treating various immune system disorders, including cancer.

Career Highlights

Throughout her career, Deborah has worked with notable organizations such as Wyeth and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to collaborate on groundbreaking research and development projects.

Collaborations

Some of her coworkers include Mary Collins and Matthew James Whitters, who have contributed to her research endeavors.

Conclusion

Deborah A Young's innovative work in the field of biotechnology showcases her dedication to advancing medical science through her patents and collaborations. Her contributions have the potential to significantly improve treatments for various immune system disorders.